Overview

Within-subject Variability of Insulin Detemir in Healthy Volunteers

Status:
Completed
Trial end date:
2004-10-31
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to compare the within-subject variability of insulin detemir to that of another basal insulin analogue, insulin glargine in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Detemir
Insulin Glargine
Insulin, Globin Zinc